Literature DB >> 26338464

Nocturnal hypoventilation in neuromuscular disease: prevalence according to different definitions issued from the literature.

Adam Ogna1, Maria-Antonia Quera Salva2, Helene Prigent3, Ghassane Mroue2, Isabelle Vaugier4, Djillali Annane5, Frederic Lofaso2,3, David Orlikowski5,4.   

Abstract

PURPOSE: Restrictive respiratory failure is a major cause of morbidity and mortality in neuromuscular diseases (NMD). Home mechanical ventilation (HMV) is used to treat hypoventilation, identified by daytime hypercapnia or nocturnal desaturation. Recently, transcutaneous measure of CO2 (TcCO2) has been increasingly used to detect hypoventilation, using different cut-offs. We aimed to compare the prevalence of hypoventilation in an unselected adult NMD population according to different definitions issued from the literature.
METHODS: All consecutive nocturnal capno-oximetries performed between 2010 and 2014 in unventilated adult NMD patients were analysed retrospectively. Concomitant blood gas analysis and lung function data were collected. Patients on oxygen therapy were excluded. Hypoventilation was defined according to eight criteria, based on daytime PaCO2, daytime base excess, nocturnal SpO2 or TcCO2.
RESULTS: Data from 232 patients were analysed (mean age 43.1 ± 15.4 years; 50.0 % women; vital capacity 59.2 ± 24.2 % of predicted). The hypoventilation prevalence was 10.3 to 61.2 %, depending on the used definition. The different definitions showed 49.1 to 94.8 % concordance (Cohen's kappa for agreement 0.115 to 0.763). Overall agreement between the eight definitions was poor (Light's kappa 0.267), and agreement between definitions based on nocturnal SpO2 and those based on TcCO2 was even lower (Light's kappa 0.204).
CONCLUSIONS: We found large differences in hypoventilation prevalence according to the used definition. This has practical consequences, as HMV indication relies upon hypoventilation detection. We believe that capno-oximetry should be included in the diagnostic tools used to detect hypoventilation but this requires an update of consensus guidelines to agree upon the best definition.

Entities:  

Keywords:  Capno-oximetry; Diagnostic criteria; Neuromuscular disease; Nocturnal hypoventilation; Nocturnal oximetry; Prevalence

Mesh:

Year:  2015        PMID: 26338464     DOI: 10.1007/s11325-015-1247-2

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  30 in total

1.  Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation.

Authors:  Michelle Eagle; Simon V Baudouin; Colin Chandler; David R Giddings; Robert Bullock; Kate Bushby
Journal:  Neuromuscul Disord       Date:  2002-12       Impact factor: 4.296

Review 2.  Chronic hypoventilation and its management.

Authors:  Anita K Simonds
Journal:  Eur Respir Rev       Date:  2013-09-01

Review 3.  Nocturnal monitoring of home non-invasive ventilation: the contribution of simple tools such as pulse oximetry, capnography, built-in ventilator software and autonomic markers of sleep fragmentation.

Authors:  Jean-Paul Janssens; Jean-Christian Borel; Jean-Louis Pépin
Journal:  Thorax       Date:  2010-10-22       Impact factor: 9.139

4.  Daytime predictors of sleep hypoventilation in Duchenne muscular dystrophy.

Authors:  C A Hukins; D R Hillman
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

5.  Mechanisms of improvement of respiratory failure in patients with restrictive thoracic disease treated with non-invasive ventilation.

Authors:  A H Nickol; N Hart; N S Hopkinson; J Moxham; A Simonds; M I Polkey
Journal:  Thorax       Date:  2005-06-06       Impact factor: 9.139

6.  Transcutaneous measurement of carbon dioxide tension during extended monitoring: evaluation of accuracy and stability, and an algorithm for correcting calibration drift.

Authors:  David J Berlowitz; Jo Spong; Fergal J O'Donoghue; Rob J Pierce; Douglas J Brown; Donald A Campbell; Peter G Catcheside; Ian Gordon; Peter D Rochford
Journal:  Respir Care       Date:  2011-01-21       Impact factor: 2.258

7.  A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients.

Authors:  C E Jackson; J Rosenfeld; D H Moore; W W Bryan; R J Barohn; M Wrench; D Myers; L Heberlin; R King; J Smith; D Gelinas; R G Miller
Journal:  J Neurol Sci       Date:  2001-10-15       Impact factor: 3.181

8.  The changing natural history of spinal muscular atrophy type 1.

Authors:  M Oskoui; G Levy; C J Garland; J M Gray; J O'Hagen; D C De Vivo; P Kaufmann
Journal:  Neurology       Date:  2007-11-13       Impact factor: 9.910

9.  Evolution of nocturnal oxyhemoglobin desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mm Hg.

Authors:  E C Fletcher; D Scott; W Qian; R A Luckett; C C Miller; S Goodnight-White
Journal:  Am Rev Respir Dis       Date:  1991-08

10.  Randomised trial of preventive nasal ventilation in Duchenne muscular dystrophy. French Multicentre Cooperative Group on Home Mechanical Ventilation Assistance in Duchenne de Boulogne Muscular Dystrophy.

Authors:  J C Raphael; S Chevret; C Chastang; F Bouvet
Journal:  Lancet       Date:  1994-06-25       Impact factor: 79.321

View more
  16 in total

Review 1.  Sleep-disordered breathing in patients with neuromuscular disease.

Authors:  Mohamad Ammar Albdewi; Giuseppe Liistro; Riëm El Tahry
Journal:  Sleep Breath       Date:  2017-07-12       Impact factor: 2.816

2.  Self-reported reduced sleep quality and excessive daytime sleepiness in facioscapulohumeral muscular dystrophy.

Authors:  Heloise M Hoffmann; Victor Malo-Juvera; Jeffrey M Statland
Journal:  Muscle Nerve       Date:  2022-08-09       Impact factor: 3.852

3.  Sleep-related breathing disorders in facioscapulohumeral dystrophy.

Authors:  Maya Runte; Jens Spiesshoefer; Anna Heidbreder; Michael Dreher; Peter Young; Tobias Brix; Matthias Boentert
Journal:  Sleep Breath       Date:  2019-04-26       Impact factor: 2.655

Review 4.  Optimal NIV Medicare Access Promotion: Patients With Thoracic Restrictive Disorders: A Technical Expert Panel Report From the American College of Chest Physicians, the American Association for Respiratory Care, the American Academy of Sleep Medicine, and the American Thoracic Society.

Authors:  Lisa F Wolfe; Joshua O Benditt; Loutfi Aboussouan; Dean R Hess; John M Coleman
Journal:  Chest       Date:  2021-07-30       Impact factor: 9.410

5.  Assessment of Nocturnal Hypoventilation by Different Methods and Definitions in Children with Neuromuscular Disease: Oxycapnography and Blood Gas Analysis.

Authors:  Yetkin Ayhan; Elif Yuksel Karatoprak; Zeynep Reyhan Onay; Sinem Can Oksay; Saniye Girit
Journal:  Medeni Med J       Date:  2021-06-18

6.  Detection of early nocturnal hypoventilation in neuromuscular disorders.

Authors:  Federica Trucco; Marina Pedemonte; Chiara Fiorillo; Hui-Leng Tan; Annalisa Carlucci; Giacomo Brisca; Paola Tacchetti; Claudio Bruno; Carlo Minetti
Journal:  J Int Med Res       Date:  2017-12-06       Impact factor: 1.671

Review 7.  Sleep and Sleep Disruption in Amyotrophic Lateral Sclerosis.

Authors:  Matthias Boentert
Journal:  Curr Neurol Neurosci Rep       Date:  2020-05-27       Impact factor: 5.081

8.  Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives.

Authors:  Matthias Boentert
Journal:  Nat Sci Sleep       Date:  2019-08-09

Review 9.  Daytime noninvasive ventilatory support for patients with ventilatory pump failure: a narrative review.

Authors:  Paolo Banfi; Paola Pierucci; Eleonora Volpato; Antonello Nicolini; Agata Lax; Dominique Robert; John Bach
Journal:  Multidiscip Respir Med       Date:  2019-11-30

10.  Prognostic Value of Initial Assessment of Residual Hypoventilation Using Nocturnal Capnography in Mechanically Ventilated Neuromuscular Patients: A 5-Year Follow-up Study.

Authors:  Adam Ogna; Julie Nardi; Helene Prigent; Maria-Antonia Quera Salva; Cendrine Chaffaut; Laure Lamothe; Sylvie Chevret; Djillali Annane; David Orlikowski; Frederic Lofaso
Journal:  Front Med (Lausanne)       Date:  2016-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.